PLENARY SESSION FIVE: Global dispute trends and strategies for effective resolution in life sciences disputes
Preeti Bhagnani , Edona Vila
PLENARY SESSION SIX: ESG compliance in action in the life sciences industry
Catherine Longeval , George Wray
Coffee/tea break
PLENARY SESSION SEVEN: Transatlantic review of patent litigation and preliminary injunction practice in pharma and biotech industries
Özge Atilgan Karakulak , Christophe Ronse
Final comments
Özge Atilgan Karakulak , Yuval Horn , Jose Alejandro Luna Fandino , Cecile Theard-Jallu